Status:
COMPLETED
18F-fluorocholine and 18F-fluoride PET in Prostate Cancer
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Conditions:
Prostate Cancer
Fluorocholine
Eligibility:
MALE
20+ years
Phase:
NA
Brief Summary
Prostate cancer remains to be a public health problem around the world. For patients with prostate cancer, diphosphonate bone scintigraphy (BS) and pelvic tomographic imaging are major imaging tools t...
Detailed Description
The investigators conducted a prospective study to investigate the performance of 18F-choline (FCH) PET/CT and 18F-NaF PET in the patients with prostate adenocarcinoma. 18F-NaF PET imaging protocol: ...
Eligibility Criteria
Inclusion
- Patients are pathologically diagnosed with prostate adenocarcinoma.
- Received NaF PET/CT.
Exclusion
- Diagnosed to have multiple cancers
- Younger than 20-year-old
- Known allergic to investigational drug
- The patients is classified as not suited for the exam by the investigators.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04340765
Start Date
February 1 2018
End Date
December 31 2019
Last Update
April 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hualien Tzu Chi Hospital
Hualien City, Taiwan, 970